Eleven associations representing the European and British life science industry, including the Association of the British Pharmaceutical Industry (ABPI), have today launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union.
The Association of the British Pharmaceutical Industry (ABPI) - representing leading global pharmaceutical businesses in the UK - have welcomed the EU Council's agreement to progress Brexit negotiations to the next phase and the EU Council's approval of a transition period.
The ABPI has responded to the Prime Minister's ‘Road to Brexit’ speech today at Mansion House.
As the MHRA publishes an update to pharmaceutical companies on preparing for Brexit, the ABPI reaffirms the importance of patient and public health in negotiations.
Making sure patients continue to get the medicines they need is of upmost importance as we negotiate the UK’s withdrawal from the EU.
Responding to a new House of Commons Health and Social Care Select Committee report ‘Brexit – Medicines, Medical Devices and Substances of Human Origin’, the trade associations representing the UK's pharmaceutical and biotech industries have issued a joint response backing the Committee's...
Last week, the EMA announced it has completed the reallocation of the medicines for which the UK's national regulator - the MHRA - is currently rapporteur or co-rapporteur appointed by the scientific committees to coordinate the evaluation of a medicine.
UK Marketing Authorisation Holders urged to register with SecurMed UK
To coincide with today’s House of Commons Health Select Committee on ‘Brexit: the regulation of medicines, medical devices and substances of human origin’, the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have published new research on the public...
The ABPI and the BIA have welcomed the UK Government’s latest Brexit position paper on ‘Collaboration on science and innovation’.
The Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have welcomed the publication of "Continuity in the availability of goods for the EU and the UK", published today by the UK Government's Department for Exiting the European Union.